# FDA EIR - Abbott Laboratories - September 24, 2021

Source: https://www.keypedia.com/records/eir/abbott-laboratories/5852760e-4717-4251-9e6f-60279ba8d184

> FDA EIR for Abbott Laboratories on September 24, 2021. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Abbott Laboratories
- Inspection Date: 2021-09-24

## Related Documents

- [483 - 2022-03-18](https://www.keypedia.com/records/483/abbott-laboratories/cddf9d08-ba82-455c-bee1-930e7156412a)
- [483 - 2021-09-24](https://www.keypedia.com/records/483/abbott-laboratories/8b16aa80-6633-49a0-b838-01ef4cbb2522)
- [EIR - 2019-09-24](https://www.keypedia.com/records/eir/abbott-laboratories/6150f618-2491-46d1-8bf6-57b5ea8e46c4)
- [483 - 2019-09-24](https://www.keypedia.com/records/483/abbott-laboratories/e64c4569-8746-4564-82aa-a4286788acf6)
- [EIR - 2018-09-18](https://www.keypedia.com/records/eir/abbott-laboratories/a951bc37-0142-4427-b446-e72c3b9ac19b)

## Related Officers

- [Scott T. Ballard](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [Director](https://www.keypedia.com/people/joann-m/0a459cd4-7849-4687-8811-4868144e3be3)
- [Medical Content Writer](https://www.keypedia.com/people/jolanna-a/204c4fa5-c69c-4ed4-8800-267788e163d2)
- [Rob Stauffer](https://www.keypedia.com/people/rob-stauffer/2f905cb4-06de-4fc0-9076-d117ae7d2114)
- [ Director, Bioresearch Monitoring Division (West) and FDA Delegate to the OECD Working Party on GLPs](https://www.keypedia.com/people/eric-s-pittman/878b3087-615d-4e1f-9a9f-0649b46b817b)

Company: https://www.keypedia.com/companies/abbott-laboratories/e395ce4f-5eb4-41bf-9d1c-df73e573f136